Skip to main content
MMedVellum
MCQsExamsAtlas
DashboardPricing
MMedVellum

The exam atlas that feels like a flagship product — evidence-graded topics and exam tools for MBBS and fellowship preparation. Built to scale to fifty specialties. Educational content only — not medical advice.

llms.txt·psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Clinical Atlas Prestige · Evidence-first

Psych CASC / OSCEChild and adolescent psychiatry — depression

Psych CASC / OSCE · Child and adolescent psychiatry — depression

Explain adolescent depression and fluoxetine plan to a parent — CASC communication station

MRCPsych/FRANZCP-style communication station: explain youth depression, rationale for fluoxetine with starting dose and monitoring, black-box risk in absolute terms, confidentiality/private interviews, school plan, and crisis pathways.

communication
On this page & tools

Target exams

FRANZCPMRCPsychABPNMD-DNB

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
You are seeing a 14-year-old with moderate major depression and her mother. The young person has agreed to fluoxetine plus CBT. Mother fears 'addiction', 'personality change', and the black-box suicide warning she read online.

Station brief

Format. Communication station, approximately 7–10 minutes. You are the psychiatry/CAMHS registrar. The examiner plays the mother; the young person may be present or represented as having consented to this discussion.[3][4]

Candidate instructions. Explain the diagnosis of adolescent major depression in plain language, the plan for CBT plus fluoxetine, expected benefits and side-effects, the black-box suicidality warning in balanced terms, early monitoring and what to do if mood or suicidal thoughts worsen, school support, and confidentiality limits. Check understanding and invite questions.[1][2][3]

Candidate scenario

The young person meets criteria for moderate major depression with falling grades and passive death wishes without plan. You plan fluoxetine 10 mg orally daily for several days then 20 mg daily, early clinical review, ongoing CBT, and a written safety plan with means restriction at home. Mother is highly anxious about medication "making her suicidal".[1][2][3]

Marking domains

  • Empathy, structure, and agenda-setting with parent (and youth if present)
  • Accurate plain-language explanation of youth depression (not "just teenage moodiness")
  • Clear medication plan: agent, approximate dose, delayed benefit, early side-effects
  • Balanced black-box discussion with monitoring plan
  • Safety-netting and crisis contacts; means restriction
  • School and therapy role; confidentiality limits explained
  • Checks understanding / teach-back [3][4]
Reveal assessor key

Open. Name time; ask mother's main fears first (addiction, personality, suicide warning). Validate concern; state shared goal of safety and recovery.[3]

Explain diagnosis. "Major depression is a medical syndrome — persistent low or irritable mood and loss of pleasure plus changes in sleep, energy, concentration and self-view lasting weeks, severe enough to affect school and life. It is common in teenagers and treatable. It is not weakness or bad parenting alone."[4]

Explain plan. CBT skills plus medication often work better together for moderate depression (TADS-style combination rationale). Fluoxetine is the best-studied antidepressant for young people. Start low (about 10 mg then 20 mg daily). Benefits build over weeks; early nausea or headache may settle. We review soon because a small number of young people feel more agitated or have more suicidal thoughts after starting — if that happens, contact us or emergency services the same day. Antidepressants are not intoxicating addictions like alcohol, but we plan duration and do not stop abruptly later without advice.[1][2][3]

Black-box in absolute terms. Studies found a small increase in reported suicidal thoughts or behaviours on antidepressants versus sugar pill in short paediatric trials; they did not show that most young people become suicidal, and untreated depression itself carries suicide risk. Our response is closer follow-up and a written safety plan, including locking surplus medication.[2][3]

Confidentiality. We will see your child alone at times; we keep private what we can, but if safety is at risk we will share what is needed with you and services — we will try to do that with your child's knowledge.[3][4]

Close. Summarise, teach-back, written info and crisis numbers, book early review, offer school liaison letter with consent.[3]

References

  1. [1]March J, Silva S, Petrycki S, et al. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial JAMA, 2004.PMID 15315995
  2. [2]Hammad TA, Laughren T, Racoosin J Suicidality in pediatric patients treated with antidepressant drugs Arch Gen Psychiatry, 2006.PMID 16520440
  3. [3]Cheung AH, Zuckerbrot RA, Jensen PS, et al. Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part II. Treatment and Ongoing Management Pediatrics, 2018.PMID 29483201
  4. [4]Malhi GS, Bell E, Bassett D, et al. The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders Aust N Z J Psychiatry, 2021.PMID 33353391